Detalles de la búsqueda
1.
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis.
J Drugs Dermatol
; 21(2): 162-171, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133113
2.
Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Epilepsia
; 61(4): 647-656, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329527
3.
A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Epilepsy Behav
; 113: 107464, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152580
4.
Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers.
Epilepsia Open
; 5(3): 451-460, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913953
5.
Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
Epilepsy Res
; 165: 106329, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623096
6.
Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice.
Epilepsia Open
; 4(3): 409-419, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440722
7.
Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Arthritis Rheumatol
; 66(7): 1820-31, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740822
Resultados
1 -
7
de 7
1
Próxima >
>>